Literature DB >> 27470534

Methods and issues in studies of CRE.

Scott R Evans1, Anthony D Harris2.   

Abstract

Carbapenem-resistant Enterobacteriaceae (CRE) are an emerging and troublesome group of pathogens. Risk factor studies, outcome studies, and randomized trials are three types of studies conducted to answer different types of questions regarding CRE. These studies pose different types of challenges. We discuss issues in the design and analyses of case-control studies, cohort studies, and randomized trials aimed to address various research questions regarding CRE.

Entities:  

Keywords:  carbapenem-resistant Enterobacteriaceae; case-control study; cohort study; competing risk; confounding variable; control group; external control; lead-time bias; randomized trial

Mesh：

Substances：

Year:  2016        PMID： 27470534      PMCID： PMC5477696          DOI： 10.1080/21505594.2016.1213473

Source DB:  PubMed          Journal:  Virulence        ISSN： 2150-5594            Impact factor:   5.882


  24 in total

Review 1.  Methodological principles of case-control studies that analyzed risk factors for antibiotic resistance: a systematic review.

Authors:  A D Harris; T B Karchmer; Y Carmeli; M H Samore
Journal:  Clin Infect Dis       Date:  2001-03-21       Impact factor: 9.079

2.  Control group selection is an important but neglected issue in studies of antibiotic resistance.

Authors:  A D Harris; M H Samore; Y Carmeli
Journal:  Ann Intern Med       Date:  2000-07-18       Impact factor: 25.391

3.  International Conference on Harmonisation; choice of control group and related issues in clinical trials; availability. Notice.

Authors: 
Journal:  Fed Regist       Date:  2001-05-14

Review 4.  The case-case-control study design: addressing the limitations of risk factor studies for antimicrobial resistance.

Authors:  Keith S Kaye; Anthony D Harris; Matthew Samore; Yehuda Carmeli
Journal:  Infect Control Hosp Epidemiol       Date:  2005-04       Impact factor: 3.254

5.  Hospital-acquired infections--appropriate statistical treatment is urgently needed!

Authors:  Martin Schumacher; Arthur Allignol; Jan Beyersmann; Nadine Binder; Martin Wolkewitz
Journal:  Int J Epidemiol       Date:  2013-09-14       Impact factor: 7.196

Review 6.  Epidemiological interpretation of studies examining the effect of antibiotic usage on resistance.

Authors:  Vered Schechner; Elizabeth Temkin; Stephan Harbarth; Yehuda Carmeli; Mitchell J Schwaber
Journal:  Clin Microbiol Rev       Date:  2013-04       Impact factor: 26.132

7.  Multistate modelling to estimate the excess length of stay associated with meticillin-resistant Staphylococcus aureus colonisation and infection in surgical patients.

Authors:  G De Angelis; A Allignol; A Murthy; M Wolkewitz; J Beyersmann; E Safran; J Schrenzel; D Pittet; S Harbarth
Journal:  J Hosp Infect       Date:  2011-04-09       Impact factor: 3.926

8.  Clinical implications of stenotrophomonas maltophilia resistant to trimethoprim-sulfamethoxazole: a study of 69 patients at 2 university hospitals.

Authors:  S Tsiodras; D Pittet; Y Carmeli; G Eliopoulos; H Boucher; S Harbarth
Journal:  Scand J Infect Dis       Date:  2000

9.  Randomized versus historical controls for clinical trials.

Authors:  H Sacks; T C Chalmers; H Smith
Journal:  Am J Med       Date:  1982-02       Impact factor: 4.965

10.  Deaths attributable to carbapenem-resistant Enterobacteriaceae infections.

Authors:  Matthew E Falagas; Giannoula S Tansarli; Drosos E Karageorgopoulos; Konstantinos Z Vardakas
Journal:  Emerg Infect Dis       Date:  2014-07       Impact factor: 6.883
View more
  9 in total

1.  Carbapenem-resistant Enterobacteriaceae: What we know and what we need to know.

Authors:  David van Duin
Journal:  Virulence       Date:  2017-04-12       Impact factor: 5.882

2.  Fundamentals and Catalytic Innovation: The Statistical and Data Management Center of the Antibacterial Resistance Leadership Group.

Authors:  Jacqueline Huvane; Lauren Komarow; Carol Hill; Thuy Tien T Tran; Carol Pereira; Susan L Rosenkranz; Matt Finnemeyer; Michelle Earley; Hongyu Jeanne Jiang; Rui Wang; Judith Lok; Scott R Evans
Journal:  Clin Infect Dis       Date:  2017-03-15       Impact factor: 9.079

3.  Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae.

Authors:  David van Duin; Judith J Lok; Michelle Earley; Eric Cober; Sandra S Richter; Federico Perez; Robert A Salata; Robert C Kalayjian; Richard R Watkins; Yohei Doi; Keith S Kaye; Vance G Fowler; David L Paterson; Robert A Bonomo; Scott Evans
Journal:  Clin Infect Dis       Date:  2018-01-06       Impact factor: 9.079

4.  Multiple antibiotic resistance as a risk factor for mortality and prolonged hospital stay: A cohort study among neonatal intensive care patients with hospital-acquired infections caused by gram-negative bacteria in Vietnam.

Authors:  Lynn Peters; Linus Olson; Dung T K Khu; Sofia Linnros; Ngai K Le; Håkan Hanberger; Ngoc T B Hoang; Dien M Tran; Mattias Larsson
Journal:  PLoS One       Date:  2019-05-08       Impact factor: 3.240

5.  A ten-year review of ESBL and non-ESBL Escherichia coli bloodstream infections among children at a tertiary referral hospital in South Africa.

Authors:  Oliver Ombeva Malande; James Nuttall; Vashini Pillay; Colleen Bamford; Brian Eley
Journal:  PLoS One       Date:  2019-09-24       Impact factor: 3.240

6.  Risk factors and survival of patients infected with carbapenem-resistant Klebsiella pneumoniae in a KPC endemic setting: a case-control and cohort study.

Authors:  Astrid V Cienfuegos-Gallet; Ana M Ocampo de Los Ríos; Patricia Sierra Viana; Faiver Ramirez Brinez; Carlos Restrepo Castro; Gustavo Roncancio Villamil; Helena Del Corral Londoño; J Natalia Jiménez
Journal:  BMC Infect Dis       Date:  2019-10-07       Impact factor: 3.090

Review 7.  Methodological quality of studies evaluating the burden of drug-resistant infections in humans due to the WHO Global Antimicrobial Resistance Surveillance System target bacteria.

Authors:  Maria Diletta Pezzani; Barbara Tornimbene; Carmem Pessoa-Silva; Marlieke de Kraker; Sebastiano Rizzardo; Nicola Duccio Salerno; Stephan Harbarth; Evelina Tacconelli
Journal:  Clin Microbiol Infect       Date:  2021-01-13       Impact factor: 8.067

8.  A comparison of risk factors for cryptosporidiosis and non-cryptosporidiosis diarrhoea: A case-case-control study in Ethiopian children.

Authors:  Øystein Haarklau Johansen; Alemseged Abdissa; Mike Zangenberg; Zeleke Mekonnen; Beza Eshetu; Bizuwarek Sharew; Sabrina Moyo; Halvor Sommerfelt; Nina Langeland; Lucy J Robertson; Kurt Hanevik
Journal:  PLoS Negl Trop Dis       Date:  2022-06-06

9.  Systematic literature review of the burden and outcomes of infections due to multidrug-resistant organisms in Europe: the ABOUT-MDRO project protocol.

Authors:  Blanca Anaya-Baz; Natalia Maldonado; Zaira R Palacios-Baena; Virginia Palomo; Maria Diletta Pezzani; Sheila Chiesi; Elisa Razzaboni; Monica Compri; Evelina Tacconelli; Jesús Rodriguez-Baño
Journal:  BMJ Open       Date:  2020-05-05       Impact factor: 2.692
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.